HB Fuller (NYSE:FUL) had its price objective increased by equities research analysts at Citigroup from $30.00 to $46.00 in a research report issued to clients and investors on Monday, The Fly reports. The firm presently has a “neutral” rating on the specialty chemicals company’s stock. Citigroup‘s price target suggests a potential upside of 3.53% from the company’s current price.
Several other research firms have also commented on FUL. TheStreet lowered shares of HB Fuller from a “b-” rating to a “c+” rating in a research note on Thursday, March 5th. Stifel Nicolaus reissued a “buy” rating and set a $54.00 target price on shares of HB Fuller in a research note on Friday, June 26th. Robert W. Baird upped their price target on shares of HB Fuller from $35.00 to $45.00 and gave the company a “neutral” rating in a research report on Friday, June 26th. ValuEngine upgraded shares of HB Fuller from a “sell” rating to a “hold” rating in a research report on Friday, May 1st. Finally, JPMorgan Chase & Co. upgraded shares of HB Fuller from a “neutral” rating to an “overweight” rating and set a $34.00 price target for the company in a research report on Friday, April 17th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the company’s stock. HB Fuller currently has an average rating of “Hold” and an average price target of $48.43.
FUL stock opened at $44.43 on Monday. HB Fuller has a 12 month low of $23.68 and a 12 month high of $52.40. The firm has a market cap of $2.19 billion, a PE ratio of 18.67, a P/E/G ratio of 2.48 and a beta of 1.81. The firm has a 50 day simple moving average of $39.13 and a 200 day simple moving average of $40.57. The company has a debt-to-equity ratio of 1.56, a current ratio of 1.89 and a quick ratio of 1.19.
Hedge funds have recently added to or reduced their stakes in the business. Chevy Chase Trust Holdings Inc. purchased a new stake in HB Fuller in the 4th quarter worth approximately $27,000. Advisor Group Holdings Inc. purchased a new stake in HB Fuller in the 1st quarter worth approximately $27,000. FMR LLC lifted its position in HB Fuller by 37.1% in the 4th quarter. FMR LLC now owns 1,005 shares of the specialty chemicals company’s stock worth $52,000 after buying an additional 272 shares in the last quarter. Americana Partners LLC purchased a new stake in HB Fuller in the 4th quarter worth approximately $59,000. Finally, Tower Research Capital LLC TRC lifted its position in HB Fuller by 367.5% in the 1st quarter. Tower Research Capital LLC TRC now owns 1,178 shares of the specialty chemicals company’s stock worth $33,000 after buying an additional 926 shares in the last quarter. Institutional investors own 96.71% of the company’s stock.
HB Fuller Company Profile
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.
Featured Article: Guidelines for Successful Channel Trading
Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.